Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Patentability Assessment: How a TTO Evaluates an Invention Disclosure

How a technology transfer office assesses novelty, non-obviousness, utility, and subject-matter eligibility to reach a file-or-don’t-file decision on a disclosed invention.

A patentability assessment is the step in a technology transfer office’s (TTO) workflow where a disclosed invention is evaluated against the legal tests a patent examiner will eventually apply, in order to reach a file-or-don’t-file decision before any money is committed to outside patent counsel. It sits between two other steps that are often confused with it: the invention disclosure itself (the researcher’s initial report) and the prior art search (the technique used to find out what’s already known). This guide is about the assessment process itself — who does it, what it weighs, and how it produces a decision — not about the underlying patent doctrine, which is covered in depth in Patent Law Requirements: The Four Tests an Invention Must Pass and the dedicated statute guides linked throughout.

What a patentability assessment is, and isn’t

A patentability assessment asks one narrow legal question: does this invention, as currently understood, have a realistic chance of meeting the statutory requirements for a U.S. patent? It is not the same as a prior art search (the research task that supplies the assessment’s raw material), a freedom-to-operate analysis, or a commercialization or market assessment.

  • Prior art search vs. patentability assessment. The search is a fact-finding exercise — running patent databases, literature, and product searches to find what already exists. The assessment is the judgment call built on top of those results: given what the search turned up, does the invention still look novel and non-obvious? See How to Conduct a Prior Art Search for the search mechanics themselves.
  • Freedom to operate (FTO) vs. patentability. These are frequently conflated but ask opposite questions. Patentability asks whether this invention can be protected. FTO asks whether making, using, or selling the invention would infringe someone else’s already-issued patent. An invention can be entirely patentable (novel and non-obvious over the prior art) and still infringe a broader existing patent if practicing it requires using someone else’s still-in-force claims — the two questions use overlapping prior-art research but produce independent answers, and a TTO can clear one without clearing the other.
  • Commercialization potential vs. patentability. Whether an invention is worth the cost of a patent (market size, licensee interest, stage of development) is a business judgment, not a legal one. Many TTOs review both together at the same disclosure-review meeting for efficiency, but they are analytically separate questions with separate failure modes: an invention can be clearly patentable and commercially uninteresting, or commercially exciting but fail the legal test outright.

Who conducts the assessment

Practice varies by institution size and budget, but the assessment is rarely done by one person in isolation:

  • The licensing associate or IP/invention manager who owns the disclosure typically does the first-pass screening — running or commissioning a prior art search, checking the invention against the four statutory questions below, and flagging obvious problems (public disclosure that already started a statutory clock, an invention that reads like a natural correlation or abstract idea) before any legal spend is authorized.
  • In-house or outside patent counsel (a registered patent attorney or patent agent) is generally the one who renders the actual legal opinion once a disclosure clears initial screening, particularly for a formal written patentability opinion or before a provisional or non-provisional application is drafted. Larger TTOs may have in-house patent counsel; smaller offices retain outside firms per-matter, often on a capped-fee basis for an initial opinion.
  • The inventor is a required input, not a bystander — the assessment depends on the inventor accurately describing what is genuinely new about the work, any public disclosures already made (conference talks, preprints, theses, sponsor reports), and enough technical detail for counsel to evaluate enablement.
  • An invention review or disclosure committee, where one exists, typically makes the final file/don’t-file call using the assessment as one input alongside commercialization potential and available budget — particularly at institutions that triage a high volume of disclosures against a fixed annual patent budget.

This intake-through-decision workflow is what AUTM (the Association of University Technology Managers) groups under “Invention Disclosure and Assessment” in its own professional curriculum, distinct from the marketing, licensing, and startup-formation stages that follow. See The Technology Transfer Process for how this step fits into the larger disclosure-to-licensing pipeline.

The four questions the assessment works through

Whatever the exact workflow, a patentability assessment is structured around the same four statutory tests a patent examiner applies, working through them roughly in this order:

1. Patent-eligible subject matter and utility (35 U.S.C. § 101)

Section 101 asks two things at once, and TTOs often only think about the first: whether the invention falls into an eligible category (a process, machine, manufacture, or composition of matter) without landing in the judge-made exceptions for laws of nature, natural phenomena, or abstract ideas (the Alice/Mayo framework), and separately, whether it is useful. The utility requirement is a low bar in practice — most disclosures clear it without discussion — but it is a real, independent test: the Supreme Court in Brenner v. Manson, 383 U.S. 519 (1966), construed “useful” in § 101 to require a specific and substantial utility, not a merely speculative or future one. A compound with no identified use, or a device with no articulable real-world benefit, can fail on utility grounds alone even if it is novel and non-obvious. Subject-matter eligibility is the harder and more consequential half of this test at most TTOs, especially for software and diagnostic-method disclosures. Full mechanics and worked examples: 35 U.S.C. § 101: Patentable Subject Matter and the Alice/Mayo Eligibility Test.

2. Novelty (35 U.S.C. § 102)

Has this exact invention already been disclosed to the public — by anyone, including the inventor — before the relevant date? Under the AIA’s first-inventor-to-file system, a single prior art reference disclosing every element of the claimed invention destroys novelty outright, and the inventor’s own conference talk, preprint, or product demo counts as prior art against their own later application outside a narrow one-year grace period. This is why the assessment has to happen early and fast relative to any planned public disclosure, not after the fact. Full mechanics: 35 U.S.C. § 102: Patent Novelty and Invention Disclosure Timing.

3. Non-obviousness (35 U.S.C. § 103)

Even an invention no single reference anticipates can still fail if the differences between it and the prior art would have been obvious to a person having ordinary skill in the relevant art. This is usually the hardest of the four questions to assess with confidence before filing, because it invites combining multiple references rather than requiring one to disclose everything — and it is the ground examiners rely on most often to reject claims. Full mechanics, including the Graham factors and KSR v. Teleflex: 35 U.S.C. § 103: Non-Obviousness, the Graham Factors, and KSR.

4. Can it actually be described? (35 U.S.C. § 112, assessed once filing is likely)

This isn’t strictly a patentability question — it’s about whether the application can be written to satisfy the disclosure requirements once the first three tests look favorable — but a competent assessment flags it early: does the inventor have enough technical detail, at the time of assessment, to support a specification that enables a person skilled in the art to make and use the full scope of what will be claimed? A thin disclosure can derail an otherwise strong patentability case downstream. Full mechanics: 35 U.S.C. § 112: The Specification, Enablement, and Written Description Requirements. For the complete map of how all four requirements interact, see Patent Law Requirements: The Four Tests an Invention Must Pass.

How the assessment feeds the file/don’t-file decision

A patentability assessment doesn’t produce a binary pass/fail on its own — it produces a documented judgment about risk, usually captured as an internal memo or a formal written opinion from patent counsel, that the TTO then weighs against non-legal factors before committing to filing fees and attorney time:

  • Strength of the legal case. A clean read across all four questions supports filing with confidence; a marginal read on non-obviousness or subject-matter eligibility might still justify filing a lower-cost provisional application to preserve a priority date while more evidence (data, a refined prior art picture, inventor input) is gathered.
  • Timing pressure. Any planned or already-occurred public disclosure (a paper, a conference talk, a sponsor report) starts or has already started the statutory bar clock under § 102, and for federally funded inventions can compress the Bayh-Dole election-of-title timeline as well — a marginal patentability case facing a hard deadline is a different decision than the same case with no deadline pressure.
  • Cost versus expected value. Assessment plus prosecution costs money the office may not recover; a weak-but-not-hopeless legal case is more likely to be filed if commercial interest is already strong, and less likely to be filed if the invention has no identified licensee path.

The realistic outcomes of an assessment are broader than a simple yes/no:

  • File a provisional application to preserve a priority date cheaply while the case develops further.
  • File a non-provisional application directly when the case is strong and there’s no reason to delay.
  • Decline to file and instead protect the invention as a trade secret, where that’s a realistic option (most often for process know-how that isn’t easily reverse-engineered from a marketed product).
  • Publish a defensive disclosure — putting the invention on the public record specifically to prevent anyone else from patenting it, without seeking a patent itself — when the invention doesn’t justify patent cost but the institution wants to preserve freedom to use it.
  • Decline to protect at all, when none of the above is worth the administrative cost.

A positive patentability assessment is not a guarantee a patent will issue — it is the TTO’s and counsel’s best pre-filing read on the odds, made with less complete information than a patent examiner will eventually have. Applications assessed as strong candidates are still narrowed, rejected in part, and sometimes abandoned during prosecution; the assessment lowers risk, it doesn’t eliminate it.

Frequently asked questions

What is a patentability assessment?

It’s the internal evaluation a technology transfer office (with input from patent counsel and the inventor) performs on a disclosed invention to judge whether it is likely to meet the statutory requirements for a U.S. patent — patent-eligible subject matter and utility (35 U.S.C. § 101), novelty (§ 102), and non-obviousness (§ 103) — before committing to the cost of filing.

How is a patentability assessment different from a prior art search?

The prior art search is the research task: finding existing patents, publications, and products relevant to the invention. The patentability assessment is the judgment built on top of those search results, applying the legal tests to decide whether the invention still looks protectable. See How to Conduct a Prior Art Search for the search methodology itself.

Who performs the patentability assessment at a university TTO?

Typically a licensing associate or IP manager does an initial screen, with a formal legal opinion coming from in-house or outside patent counsel once a disclosure clears that first pass. The inventor supplies essential technical input throughout, and many offices route the final file/don’t-file call through an invention review committee.

Does a favorable patentability assessment guarantee the patent will be granted?

No. It’s a pre-filing estimate of risk based on the information available at the time, not a determination by the USPTO. Examiners can and do find prior art or raise obviousness arguments that weren’t apparent during the internal assessment, and claims are routinely narrowed during prosecution even for applications that were assessed as strong.

What happens if an invention fails the patentability assessment?

The TTO doesn’t have to abandon the invention entirely — common alternatives include trade secret protection where the invention isn’t easily reverse-engineered, a defensive publication to prevent third parties from patenting it later, or simply declining to invest further institutional resources in protecting it while leaving the inventor free to publish.

For the broader disclosure-to-licensing pipeline this step sits inside, see The Technology Transfer Process: From Invention Disclosure to Licensing and Revenue Distribution. For the intake step that precedes assessment, see Invention Disclosure: What Researchers Submit to a TTO, and Why Timing Matters. For how a disclosure differs from the patent application that may eventually follow a positive assessment, see Invention Disclosure vs. Patent Application.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →